JPY 4895.0
(1.03%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 12.24 Billion JPY | 12.79% |
2022 | 11.56 Billion JPY | 9.03% |
2021 | 10.05 Billion JPY | 1.51% |
2020 | 9.76 Billion JPY | -34.72% |
2019 | 13.81 Billion JPY | 13.26% |
2018 | 13.23 Billion JPY | 12.09% |
2017 | 11.87 Billion JPY | 25.11% |
2016 | 9.4 Billion JPY | 0.54% |
2015 | 8.87 Billion JPY | 14.53% |
2014 | 8.52 Billion JPY | -2.66% |
2013 | 8.62 Billion JPY | -66.57% |
2012 | 7.22 Billion JPY | 0.0% |
2011 | 7.34 Billion JPY | -100.0% |
2010 | 4.71 Billion JPY | -19.43% |
2009 | 5.62 Billion JPY | -14.99% |
2008 | 8.07 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 3.75 Billion JPY | 46.11% |
2024 Q2 | 2.87 Billion JPY | -23.46% |
2024 Q3 | 3.12 Billion JPY | 8.63% |
2023 Q3 | 3.35 Billion JPY | 23.78% |
2023 Q4 | 2.52 Billion JPY | -24.55% |
2023 Q1 | 3.6 Billion JPY | 41.64% |
2023 FY | - JPY | 12.79% |
2023 Q2 | 2.7 Billion JPY | -24.97% |
2022 Q4 | 2.54 Billion JPY | -22.53% |
2022 FY | - JPY | 9.03% |
2022 Q3 | 3.28 Billion JPY | 77.78% |
2022 Q2 | 1.85 Billion JPY | -40.86% |
2022 Q1 | 3.12 Billion JPY | 59.35% |
2021 FY | - JPY | 1.51% |
2021 Q4 | 1.96 Billion JPY | -28.59% |
2021 Q1 | 3.36 Billion JPY | 111.59% |
2021 Q2 | 1.84 Billion JPY | -45.03% |
2021 Q3 | 2.74 Billion JPY | 48.84% |
2020 Q1 | 3.78 Billion JPY | -12.66% |
2020 Q2 | 2.11 Billion JPY | -44.12% |
2020 Q3 | 2.28 Billion JPY | 8.33% |
2020 Q4 | 1.58 Billion JPY | -30.62% |
2020 FY | - JPY | -34.72% |
2019 Q4 | 4.32 Billion JPY | 14.37% |
2019 Q2 | 2.42 Billion JPY | -45.18% |
2019 FY | - JPY | 13.26% |
2019 Q1 | 4.42 Billion JPY | 66.12% |
2019 Q3 | 3.78 Billion JPY | 55.95% |
2018 Q3 | 3.78 Billion JPY | 57.82% |
2018 FY | - JPY | 12.09% |
2018 Q4 | 2.66 Billion JPY | -29.55% |
2018 Q2 | 2.39 Billion JPY | -45.16% |
2018 Q1 | 4.37 Billion JPY | 102.92% |
2017 Q3 | 4.18 Billion JPY | 126.67% |
2017 FY | - JPY | 25.11% |
2017 Q1 | 3.6 Billion JPY | 93.93% |
2017 Q2 | 1.84 Billion JPY | -48.88% |
2017 Q4 | 2.15 Billion JPY | -48.49% |
2016 Q1 | 3.11 Billion JPY | 43.99% |
2016 FY | - JPY | 0.54% |
2016 Q4 | 1.86 Billion JPY | -39.83% |
2016 Q3 | 3.09 Billion JPY | 128.43% |
2016 Q2 | 1.35 Billion JPY | -56.55% |
2015 Q2 | 1.36 Billion JPY | -50.7% |
2015 FY | - JPY | 14.53% |
2015 Q4 | 2.16 Billion JPY | -29.69% |
2015 Q1 | 2.76 Billion JPY | 92.69% |
2015 Q3 | 3.07 Billion JPY | 125.66% |
2014 Q4 | 1.43 Billion JPY | -11.07% |
2014 Q1 | 2.85 Billion JPY | 99.02% |
2014 Q3 | 1.61 Billion JPY | -29.25% |
2014 FY | - JPY | -2.66% |
2014 Q2 | 2.28 Billion JPY | -19.94% |
2013 Q2 | 1.3 Billion JPY | -48.57% |
2013 Q4 | 1.43 Billion JPY | -54.43% |
2013 Q3 | 3.14 Billion JPY | 141.53% |
2013 Q1 | 2.53 Billion JPY | -86.98% |
2013 FY | - JPY | -66.57% |
2012 Q3 | 2.51 Billion JPY | 214.01% |
2012 FY | - JPY | 0.0% |
2012 Q1 | 2.39 Billion JPY | -76.39% |
2012 Q2 | 801.17 Million JPY | -66.58% |
2012 Q4 | 19.43 Billion JPY | 672.52% |
2011 Q3 | 2.14 Billion JPY | 0.0% |
2011 FY | - JPY | -100.0% |
2011 Q4 | 10.15 Billion JPY | 373.33% |
2010 FY | - JPY | -19.43% |
2009 FY | - JPY | -14.99% |
2008 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kitanotatsujin Corporation | 1.58 Billion JPY | -671.078% |
Euglena Co., Ltd. | 676 Million JPY | -1711.243% |
BEAUTY GARAGE Inc. | 1.96 Billion JPY | -523.158% |
Axas Holdings Co.,Ltd. | 555.75 Million JPY | -2103.117% |
C.I. Medical Co.,Ltd. | 4.01 Billion JPY | -205.108% |
Kao Corporation | 154.49 Billion JPY | 92.075% |
Niitaka Co., Ltd. | 1.36 Billion JPY | -794.034% |
Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 74.938% |
Shiseido Company, Limited | 106.46 Billion JPY | 88.499% |
Lion Corporation | 42.31 Billion JPY | 71.064% |
Mandom Corporation | 6.69 Billion JPY | -82.774% |
Ivy Cosmetics Corporation | 242.6 Million JPY | -4946.991% |
Milbon Co., Ltd. | 7.8 Billion JPY | -56.966% |
Nippon Shikizai, Inc. | 1.28 Billion JPY | -850.196% |
Fancl Corporation | 16.6 Billion JPY | 26.254% |
KOSÉ Corporation | 26.85 Billion JPY | 54.41% |
Cota Co., Ltd. | 2.26 Billion JPY | -439.748% |
HABA Laboratories,Inc. | -1.31 Billion JPY | 1031.591% |
C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -7024.943% |
Pola Orbis Holdings Inc. | 23.17 Billion JPY | 47.172% |
Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -9774.194% |
Almado, Inc. | 983.21 Million JPY | -1145.299% |
I-ne CO., LTD. | 4.7 Billion JPY | -160.511% |
Premier Anti-Aging Co., Ltd. | -627 Million JPY | 2052.791% |
Liberta Co.,Ltd. | 318.19 Million JPY | -3747.991% |
AXXZIA Inc. | 1.28 Billion JPY | -851.724% |
S.T. Corporation | 2.62 Billion JPY | -366.26% |
Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 61.356% |
Earth Corporation | 10.6 Billion JPY | -15.422% |
Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | -1018.637% |
Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 2233.172% |
Ya-Man Ltd. | 1.43 Billion JPY | -752.189% |
MTG Co., Ltd. | 4.39 Billion JPY | -178.653% |
TRANSACTION CO.,Ltd. | 5.8 Billion JPY | -110.767% |
SHOBIDO Corporation | 1.11 Billion JPY | -1002.868% |
Artnature Inc. | 3.78 Billion JPY | -223.317% |
Pigeon Corporation | 15.8 Billion JPY | 22.536% |
Unicharm Corporation | 178.01 Billion JPY | 93.122% |
Paltac Corporation | 35.92 Billion JPY | 65.916% |
CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | -272.725% |